Eric Karran
Chief Tech/Sci/R&D Officer at Alzheimer’s Research UK
Eric Karran active positions
Companies | Position | Start |
---|---|---|
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | Chief Tech/Sci/R&D Officer | - |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Alzheimer’s Research UK
Alzheimer’s Research UK Miscellaneous Commercial ServicesCommercial Services Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease. | Commercial Services |
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Eric Karran